Mr. Zhiyue LI, known as Jerry Li, is currently the global CFO for MicuRx Pharmaceuticals and President of MicuRx US. Mr Li lead MicuRx through their IPO on the Shanghai Star Exchanges in August 2022. He directs the company’s global strategy, capital investment, investor relations, and daily operations. Mr. Li joined MicuRx in March 2018.
Before joining MicuRx, Mr. Li worked for China Resources (Holdings) Co. Ltd and its healthcare business unit from 2011 to 2017 and was Deputy Head of Treasury of Finance Department of China Resources (Holdings) and CFO of China Resources Healthcare Group. Prior to China Resources group, Mr. Li worked at Credit Agricole CIB, Shinhan Asia Limited, Hong Kong Monetary Authority, and Bank of China.
Mr. Li is a CFA Charterholder with Master in Finance degree from London Business School and Bachelor in Economics degree from Renmin University of China.
Before joining MicuRx, Mr. Li worked for China Resources (Holdings) Co. Ltd and its healthcare business unit from 2011 to 2017 and was Deputy Head of Treasury of Finance Department of China Resources (Holdings) and CFO of China Resources Healthcare Group. Prior to China Resources group, Mr. Li worked at Credit Agricole CIB, Shinhan Asia Limited, Hong Kong Monetary Authority, and Bank of China.
Mr. Li is a CFA Charterholder with Master in Finance degree from London Business School and Bachelor in Economics degree from Renmin University of China.
Speaking In
3:30 PM - 3:45 PM
Wednesday, June 7
